Basics Precision BioSciences, Inc. IPO Date: May 25, 2019 Sector: Healthcare Industry: Biotech Market Cap: $120.84M Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 3.67% Avg Daily Range (30 D): $0.26 | 4.17% Avg Daily Range (90 D): $0.18 | 3.19% Institutional Daily Volume Avg Daily Volume: .59M Avg Daily Volume (30 D): .19M Avg Daily Volume (90 D): .12M Trade Size Avg Trade Size (Sh.): 166 Avg Trade Size (Sh.) (30 D): 83 Avg Trade Size (Sh.) (90 D): 100 Institutional Trades Total Inst.Trades: 324 Avg Inst. Trade: $1.41M Avg Inst. Trade (30 D): $.77M Avg Inst. Trade (90 D): $.72M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.55M Avg Closing Trade (30 D): $.62M Avg Closing Trade (90 D): $.62M Avg Closing Volume: 7.43K     News Mar 5, 2025 @ 6:00 PM CAR T-cell Therapy Clinical Trial Pipeline Experie... Source: Delveinsight Sep 10, 2024 @ 9:00 AM Global Genetic Engineering Market Size To Worth US... Source: Spherical Insights & Consulting Sep 10, 2024 @ 8:51 AM Gene Editing Therapeutics Market Forecast 2024-202... Source: Researchandmarkets.Com May 29, 2024 @ 1:55 PM Does Precision BioSciences (DTIL) Have the Potenti... Source: Zacks Equity Research May 16, 2024 @ 6:00 PM Deep Dive Into Precision BioSciences Stock: Analys... Source: Benzinga Insights Financials   TTM Q3 2025 Q2 2025 Basic EPS $-8.96 $-1.84 $-2.13 Diluted EPS $-8.88 $-1.84 $-2.13 Revenue $ .7M $ .01M $ .02M Gross Profit $ $ $ Net Income / Loss $ -83.6M $ -21.77M $ -23.52M Operating Income / Loss $ -89.5M $ -20.67M $ -21.88M Cost of Revenue $ $ $ Net Cash Flow $ -50.12M $ -13.59M $ -14.98M PE Ratio     Splits Feb 14, 2024:   1:30